- Home
- XYL vs VTR Comparison
XYL vs VTR Comparison
Compare XYL & VTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XYL
- VTR
- Stock Information
- Founded
- XYL 2011
- VTR 1983
- Country
- XYL United States
- VTR United States
- Employees
- XYL N/A
- VTR N/A
- Industry
- XYL Fluid Controls
- VTR Real Estate Investment Trusts
- Sector
- XYL Industrials
- VTR Real Estate
- Exchange
- XYL Nasdaq
- VTR Nasdaq
- Market Cap
- XYL 29.3B
- VTR 24.7B
- IPO Year
- XYL N/A
- VTR 1998
- Fundamental
- Price
- XYL $121.90
- VTR $60.29
- Analyst Decision
- XYL Buy
- VTR Buy
- Analyst Count
- XYL 11
- VTR 10
- Target Price
- XYL $152.10
- VTR $62.80
- AVG Volume (30 Days)
- XYL 1.1M
- VTR 3.0M
- Earning Date
- XYL 02-04-2025
- VTR 02-12-2025
- Dividend Yield
- XYL 1.19%
- VTR 3.00%
- EPS Growth
- XYL 41.22
- VTR N/A
- EPS
- XYL 3.42
- VTR N/A
- Revenue
- XYL $8,424,000,000.00
- VTR $4,797,115,000.00
- Revenue This Year
- XYL $16.51
- VTR N/A
- Revenue Next Year
- XYL $4.94
- VTR $8.75
- P/E Ratio
- XYL $35.68
- VTR N/A
- Revenue Growth
- XYL 24.76
- VTR 10.05
- 52 Week Low
- XYL $111.66
- VTR $41.45
- 52 Week High
- XYL $146.08
- VTR $67.61
- Technical
- Relative Strength Index (RSI)
- XYL 59.95
- VTR 56.83
- Support Level
- XYL $113.26
- VTR $56.97
- Resistance Level
- XYL $117.88
- VTR $59.49
- Average True Range (ATR)
- XYL 2.00
- VTR 1.05
- MACD
- XYL 0.88
- VTR 0.37
- Stochastic Oscillator
- XYL 94.74
- VTR 95.76
About XYL Xylem Inc. New
Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $7.4 billion in revenue in 2023.
About VTR Ventas Inc.
Ventas owns a diversified healthcare portfolio of over 1,300 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.